4.8 (663) · $ 156.50 · In stock
Description
LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model: Molecular Therapy - Nucleic Acids
Frontiers The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson's Disease
The V-ATPase-ATG16L1 axis recruits LRRK2 to facilitate lysosomal stress responses
Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants
IJMS, Free Full-Text
Frontiers Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases
Parkinson's disease kinase LRRK2 coordinates a cell-intrinsic itaconate-dependent defence pathway against intracellular Salmonella
The V-ATPase-ATG16L1 axis recruits LRRK2 to facilitate lysosomal stress responses
LRRK2 - Wikipedia
Lee Kimball (@LRK2) / X
Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
Chemoproteomics Reveals the Antiproliferative Potential of Parkinson's Disease Kinase Inhibitor LRRK2-IN-1 by Targeting PCNA Protein
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons